Target intelligence / Profile preview

PRKAR2B antisense RNA 1 (PRKAR2B-AS1)

Target
PRKAR2B-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

PRKAR2B antisense RNA 1 (PRKAR2B-AS1) is an antisense long non-coding RNA (lncRNA) transcribed from the region opposite to the *PRKAR2B* gene locus. Antisense lncRNAs commonly function by binding to complementary mRNA from the sense gene, modulating its stability, translation, chromatin state, or transcriptional activity. There is no direct evidence in current biomedical literature establishing PRKAR2B-AS1 as a therapeutic target, disease biomarker, or druggable entity. Its function is presumed to involve classic cis-acting antisense RNA regulation, such as influencing *PRKAR2B* gene expression. The *PRKAR2B* coding gene encodes a regulatory subunit of protein kinase A involved in cell signaling, but this is distinct from the antisense transcript. Most references to PRKAR2B, as a disease gene or drug target, are about the protein-coding gene, not the antisense RNA. The sequence, function, and disease association of PRKAR2B-AS1 itself are not well established in public databases or recent literature.

Other names
PRKAR2B-AS1PRKAR2B-ASpossible locus-based names
02

Mechanism of action

Antisense RNA mechanisms (blocking translation, recruiting degradation machinery, epigenetic regulation)

03

Biological functions

Gene expression regulation (primarily via antisense mechanisms)Potential modulation of chromatin or mRNA stability
04

Disease associations

None directly documented for PRKAR2B-AS1 itself

Beyond the preview

Go deeper on PRKAR2B antisense RNA 1 (PRKAR2B-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRKAR2B antisense RNA 1 (PRKAR2B-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call